Arcutis Biotherapeutics, Inc.
$23.78
-1.09 (-4.38%)
Price as of Aug 28, 2026 market close
Performance
- 1 Month
- -15.0%
- 3 Months
- +10.8%
- YTD
- -18.1%
- 1 Year
- +51.9%
Price return, based on split- and dividend-adjusted closing prices.
Risk
- Volatility 1-year annualized
- 56.3%
- Largest decline max drawdown, since Aug 2025
- -37.5%
- Risk-adjusted return Sharpe ratio, 1-year
- 1.01
Own ARQT?
See how ARQT contributes to your portfolio's return, allocation, and risk.
7-day free trial, then $9/month.